Human rhinovirus 14 complexed with antiviral compound R 61837

Michael Chapman, Iwona Minor, Michael G. Rossmann, Guy D. Diana, Koen Andries

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The binding of the antirhinoviral agent R 61837 to human rhinovirus 14 has been examined by X-ray crystallographic methods. The compound R 61837 binds in the same pocket (underneath the canyon floor) as the "WIN" antirhinoviral agents. It does not penetrate as far into the pocket but causes similar conformational changes in the virus capsid. The movement of residues 1217 to 1221 of viral protein 1 (in the "FMDV loop") is more pronounced for R 61837 than for WIN compounds. Although both R 61837 and WIN antiviral agents partially fill the same hydrophobic pocket, atomic binding interactions differ, showing that considerable diversity in the nature of antiviral agents is possible.

Original languageEnglish (US)
Pages (from-to)455-463
Number of pages9
JournalJournal of Molecular Biology
Volume217
Issue number3
DOIs
StatePublished - Feb 5 1991
Externally publishedYes

Fingerprint

R 61837
Rhinovirus
Antiviral Agents
Capsid
Viral Proteins
X-Rays
Viruses

ASJC Scopus subject areas

  • Virology

Cite this

Human rhinovirus 14 complexed with antiviral compound R 61837. / Chapman, Michael; Minor, Iwona; Rossmann, Michael G.; Diana, Guy D.; Andries, Koen.

In: Journal of Molecular Biology, Vol. 217, No. 3, 05.02.1991, p. 455-463.

Research output: Contribution to journalArticle

Chapman, Michael ; Minor, Iwona ; Rossmann, Michael G. ; Diana, Guy D. ; Andries, Koen. / Human rhinovirus 14 complexed with antiviral compound R 61837. In: Journal of Molecular Biology. 1991 ; Vol. 217, No. 3. pp. 455-463.
@article{6a4730360873442a8c766edc28220a50,
title = "Human rhinovirus 14 complexed with antiviral compound R 61837",
abstract = "The binding of the antirhinoviral agent R 61837 to human rhinovirus 14 has been examined by X-ray crystallographic methods. The compound R 61837 binds in the same pocket (underneath the canyon floor) as the {"}WIN{"} antirhinoviral agents. It does not penetrate as far into the pocket but causes similar conformational changes in the virus capsid. The movement of residues 1217 to 1221 of viral protein 1 (in the {"}FMDV loop{"}) is more pronounced for R 61837 than for WIN compounds. Although both R 61837 and WIN antiviral agents partially fill the same hydrophobic pocket, atomic binding interactions differ, showing that considerable diversity in the nature of antiviral agents is possible.",
author = "Michael Chapman and Iwona Minor and Rossmann, {Michael G.} and Diana, {Guy D.} and Koen Andries",
year = "1991",
month = "2",
day = "5",
doi = "10.1016/0022-2836(91)90749-V",
language = "English (US)",
volume = "217",
pages = "455--463",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Human rhinovirus 14 complexed with antiviral compound R 61837

AU - Chapman, Michael

AU - Minor, Iwona

AU - Rossmann, Michael G.

AU - Diana, Guy D.

AU - Andries, Koen

PY - 1991/2/5

Y1 - 1991/2/5

N2 - The binding of the antirhinoviral agent R 61837 to human rhinovirus 14 has been examined by X-ray crystallographic methods. The compound R 61837 binds in the same pocket (underneath the canyon floor) as the "WIN" antirhinoviral agents. It does not penetrate as far into the pocket but causes similar conformational changes in the virus capsid. The movement of residues 1217 to 1221 of viral protein 1 (in the "FMDV loop") is more pronounced for R 61837 than for WIN compounds. Although both R 61837 and WIN antiviral agents partially fill the same hydrophobic pocket, atomic binding interactions differ, showing that considerable diversity in the nature of antiviral agents is possible.

AB - The binding of the antirhinoviral agent R 61837 to human rhinovirus 14 has been examined by X-ray crystallographic methods. The compound R 61837 binds in the same pocket (underneath the canyon floor) as the "WIN" antirhinoviral agents. It does not penetrate as far into the pocket but causes similar conformational changes in the virus capsid. The movement of residues 1217 to 1221 of viral protein 1 (in the "FMDV loop") is more pronounced for R 61837 than for WIN compounds. Although both R 61837 and WIN antiviral agents partially fill the same hydrophobic pocket, atomic binding interactions differ, showing that considerable diversity in the nature of antiviral agents is possible.

UR - http://www.scopus.com/inward/record.url?scp=0025966975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025966975&partnerID=8YFLogxK

U2 - 10.1016/0022-2836(91)90749-V

DO - 10.1016/0022-2836(91)90749-V

M3 - Article

C2 - 1847215

AN - SCOPUS:0025966975

VL - 217

SP - 455

EP - 463

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 3

ER -